Endocrine disrupting compounds and prostate cancer
Abstract
Prostate cancer is a major health concern and is treated based on its hormone dependence. Agents that alter hormone action can have substantial biological effects on prostate cancer development and progression. As such, there is significant interest in uncovering the potential effects of endocrine disrupting compound (EDC) exposure on prostate cancer. The present review is focused on agents that alter hormone action in the prostate and how they may impact cancer growth or treatment.
Keywords: Endocrine disrupting compound, Prostate cancer, Estrogen, Androgen, Environmental, Phytoestrogen
To access this article, please choose from the options below
PII: S0304-3835(05)00915-8
doi:10.1016/j.canlet.2005.10.006
© 2006 Elsevier Ireland Ltd. All rights reserved.
